|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0027651,
umls-concept:C0149978,
umls-concept:C0205179,
umls-concept:C0445204,
umls-concept:C0521115,
umls-concept:C0684321,
umls-concept:C0936116,
umls-concept:C1446539,
umls-concept:C1514888,
umls-concept:C1522449,
umls-concept:C2698872
|
|
pubmed:issue |
76
|
|
pubmed:dateCreated |
2007-7-16
|
|
pubmed:abstractText |
Predictors of sensitivity to preoperative radiotherapy (RT) may differ from those of chemo-radiotherapy (CRT). This study attempts to evaluate retrospectively the significance of apoptosis-related and proliferative indexes in biopsy specimens obtained before treatment as predictors of sensitivity to RT or to CRT for locally advanced rectal adenocarcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1107-12
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17629049-Adenocarcinoma,
pubmed-meshheading:17629049-Aged,
pubmed-meshheading:17629049-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17629049-Apoptosis,
pubmed-meshheading:17629049-Drug Resistance, Neoplasm,
pubmed-meshheading:17629049-Female,
pubmed-meshheading:17629049-Humans,
pubmed-meshheading:17629049-Male,
pubmed-meshheading:17629049-Middle Aged,
pubmed-meshheading:17629049-Preoperative Care,
pubmed-meshheading:17629049-Prognosis,
pubmed-meshheading:17629049-Radiation Tolerance,
pubmed-meshheading:17629049-Rectal Neoplasms,
pubmed-meshheading:17629049-Tegafur,
pubmed-meshheading:17629049-Treatment Outcome,
pubmed-meshheading:17629049-Tumor Markers, Biological,
pubmed-meshheading:17629049-Uracil
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Predictors of tumor downsizing and regression with preoperative radiotherapy alone and with concomitant tegafur/uracil (UFT) for resectable advanced rectal adenocarcinoma.
|
|
pubmed:affiliation |
Department of Surgery, Tokai University, School of Medicine Isehara, Kanagawa, Japan. sadahiro@is.icc.u-tokai.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
